Notch signaling is a cell-to-cell communication mechanism critical for embryonic development and adult homeostasis. To communicate information between cells, Notch receptors on a given cell need to be activated by ligands from neighboring cells. One of the Notch pathway ligands with broad biological roles is called jagged1. Heterozygosity for the jagged1 gene in humans results in Alagille syndrome, which is a multisystem developmental disorder characterized by bile duct abnormalities and defects in other organs systems including the cardiovascular system, kidney and skeleton. The clinical presentation of Alagille syndrome is extremely variable, even in patients with identical point mutations. Accordingly, it has been proposed that genetic modifiers play an important role in the pathophysiology of this disease. Moreover, no mechanism-based treatment has yet been established for Alagille syndrome. We have recently reported a mouse model for Alagille syndrome and have identified the glycosyltransferase gene Poglut1 as a dominant genetic suppressor of the phenotypes in this model. In this proposal, we will use biochemical and cell culture assays, transcriptional profiling and mouse genetic experiments to determine the mechanism of jagged1 regulation by glycosylation and to identify critical targets of jagged1 during bile duct development. We will also use our preliminary data and mouse model as a basis to establish a potential therapeutic approach for Alagille syndrome. These studies have the potential to provide novel insight into the pathophysiology of this disease and the molecular mechanisms underlying the regulation of jagged1-mediated signaling by glycosylation.

Public Health Relevance

Mutations in the jagged1 gene affect the development of the biliary system, heart, vasculature and other organs in human patients. The proposed studies examine the role of glycosylation in regulating the function of jagged1 and establish a potential therapeutic approach for diseases caused by decreased jagged1 function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK109982-01
Application #
9153036
Study Section
Therapeutic Approaches to Genetic Diseases Study Section (TAG)
Program Officer
Doo, Edward
Project Start
2016-07-15
Project End
2020-06-30
Budget Start
2016-07-15
Budget End
2017-06-30
Support Year
1
Fiscal Year
2016
Total Cost
$485,824
Indirect Cost
$155,411
Name
Baylor College of Medicine
Department
Genetics
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Adams, Joshua M; Jafar-Nejad, Hamed (2018) A New Model of Alagille Syndrome With Broad Phenotypic Representation. Gastroenterology 154:803-806
Galeone, Antonio; Han, Seung Yeop; Huang, Chengcheng et al. (2017) Tissue-specific regulation of BMP signaling by Drosophila N-glycanase 1. Elife 6: